Low ovarian reserve is one of the most emotionally difficult diagnoses a woman can receive during a fertility journey. The numbers arrive attached to a clinical interpretation that feels like a verdict: AMH below 1.0 ng/mL, antral follicle count of three or four, the attending clinician's careful wording that the chances with own eggs may be limited.
But the diagnosis of diminished ovarian reserve is a description of current reserve, not a fixed statement about conception potential. Many women with low AMH conceive with their own eggs when the right specialist applies the right protocol.
Finding the best fertility treatment for low ovarian reserve requires a clinician who manages this patient group specifically and frequently, not one who applies a standard protocol to all comers. Dr. Preeti Mahawar at Nova IVF Fertility Centre, Kolkata, is among a small cohort of Indian fertility specialists who lists decreased ovarian reserve as a primary clinical focus and who has over 20 years of experience and a research publication specifically on minimal stimulation in poor responders. For international patients, India offers access to this specialist depth at 60 to 80 percent lower cost than Western equivalents.
What Low Ovarian Reserve Actually Means
Low ovarian reserve, also called diminished ovarian reserve (DOR), is defined by laboratory and ultrasound parameters that collectively indicate a reduced pool of follicles available for stimulation. It is not a single fixed threshold but a clinical picture that requires interpretation in context.
The Key Parameters
- AMH (Anti-Mullerian Hormone): Produced by granulosa cells of small growing follicles and is the most reliable single marker of ovarian reserve. Values below 1.0 to 1.1 ng/mL are generally considered low. Values below 0.5 ng/mL indicate severely diminished reserve.
- Antral Follicle Count (AFC): Counted by transvaginal ultrasound on cycle day two or three. An AFC below five to seven indicates poor expected response to stimulation.
- Day 3 FSH: Elevated FSH reflects the pituitary working harder to recruit follicles. Values consistently above ten to twelve IU/L alongside low AMH confirm poor reserve.
- Day 3 Oestradiol: Elevated day 3 oestradiol alongside elevated FSH confirms early follicular recruitment and reduced reserve.
A single low AMH result should always be interpreted alongside AFC and clinical history. AMH can fluctuate and a single value taken at a point of stress, illness, or unusual cycle timing may not reflect the true baseline.
Who Is Affected
DOR is most commonly an age-related phenomenon, with AMH declining from the mid-thirties onward. However, DOR can occur in younger women due to genetic factors (including premature ovarian insufficiency, associated with Turner syndrome or FMR1 premutations), prior ovarian surgery (particularly for endometriomas), chemotherapy or pelvic radiation, autoimmune conditions, or idiopathic causes without any identifiable explanation.
Why Protocol Selection Is the Critical Variable in DOR
The most important clinical decision in managing low ovarian reserve is not whether to try IVF, but which protocol to use and how to optimise it for the individual's specific reserve parameters. Standard protocols designed for normal responders produce significantly worse outcomes in DOR patients because they suppress the ovaries during a lengthy downregulation phase before stimulation begins.
What Does Not Work Well for DOR
- Long agonist (downregulation) protocols: GnRH agonist downregulation suppresses the ovary before stimulation begins. In patients with already-depleted reserve, this suppression can reduce the follicular cohort further, resulting in poor response or cycle cancellation.
- Waiting through multiple failed stimulation cycles with the same protocol: A failed cycle is clinical data. Applying the same protocol again without modification after a poor response in a DOR patient is not a reasonable approach.
Protocols That Perform Better in DOR
- GnRH Antagonist Protocol: The most widely used protocol for poor responders. Stimulation begins immediately without a downregulation phase, preserving the existing follicular cohort. The antagonist is added later in the stimulation phase to prevent premature LH surge, rather than suppressing the ovary from the outset.
- Mild or Minimal Stimulation IVF (Mini-IVF): Uses lower doses of gonadotrophins, sometimes combined with oral clomiphene or letrozole, to recruit the follicles that are genuinely available rather than chasing a larger number with high doses. It is particularly relevant for DOR patients where high-dose stimulation produces diminishing returns. Dr. Preeti Mahawar presented a retrospective analysis titled "Retrospective analysis of minimal stimulation in poor responder" at the Annual Conference of ISAR Bengal in 2016, reflecting her specific research interest in this protocol category for exactly this patient group.
- Testosterone Priming: Short-course transdermal testosterone applied to the skin before stimulation may improve ovarian response in DOR patients by increasing androgen receptor expression in follicles. Evidence is mixed but promising in selected patients.
- DHEA Supplementation: Dehydroepiandrosterone supplementation for 12 weeks before stimulation has evidence for improving AMH, AFC, and IVF outcomes in a subset of DOR patients, particularly those with autoimmune contributions to their reserve decline.
- Growth Hormone Adjuvant: Low-dose growth hormone co-administered during the stimulation phase improves ovarian response in poor responders in multiple randomised trials, increasing the number of mature oocytes retrieved and improving fertilisation rates in this specific group.
- Natural or Modified Natural Cycle IVF: For women with very severely diminished reserve where stimulation consistently retrieves only one or two eggs regardless of protocol, natural cycle IVF retrieves the single dominant follicle that develops each month without medication. While the per-cycle probability is lower, the cumulative probability across multiple low-cost natural cycles can be comparable to a single heavily medicated cycle.
- Accumulation Strategy and Egg Banking: Back-to-back stimulation cycles retrieve whatever eggs are available each month, freeze them, and accumulate embryos for a batch transfer after PGT-A screening. This approach spreads the limited reserve across multiple retrievals and builds a testable embryo pool.
When Donor Eggs Become the Right Conversation
Not every woman with DOR will achieve pregnancy with her own eggs, and the conversation about donor eggs is one that the best fertility specialists for low ovarian reserve approach with both clinical honesty and genuine respect for the patient's autonomy and timeline. The clinical indicators that suggest moving toward donor egg consideration include:
- Consistently zero or one mature egg per retrieval across multiple modified protocols
- Repeated fertilisation failure despite ICSI with good sperm quality
- No euploid embryos on PGT-A across multiple retrievals in a woman over 40
- Premature ovarian insufficiency with FSH consistently above 40 IU/L
The decision to use donor eggs is deeply personal and is not determined by AMH alone. Many specialists would encourage at least one or two own-egg attempts with optimised protocols before recommending transition, unless the clinical picture makes own-egg success genuinely implausible.
Donor egg IVF at Nova IVF Kolkata is available under India's 2021 ART Regulation Act, with anonymous health-screened donors under 30 and legally structured consent documentation.
Dr. Preeti Mahawar: Her Approach to Low Ovarian Reserve at Nova IVF Kolkata
Dr. Preeti Mahawar is a Fertility Consultant at Nova IVF Fertility East, Uttam Kumar Sarani, Kolkata, with the following qualifications:
-
MBBS from Calcutta National Medical College, Kolkata (1998)
-
DGO from Calcutta National Medical College, Kolkata (2003)
-
DNB in Gynaecology and Obstetrics from B.R. Singh Railway Hospital, Kolkata (2005)
-
FOGSI-certified Gynaecological Endoscopic Training from ILS Hospital
-
ART Diploma from ISRME (Indian Society of Reproductive Medicine and Embryology), covering basic and advanced assisted reproductive techniques
Her clinical focus is specifically on decreased ovarian reserve, PCOS, and male factor infertility, which means DOR patients are a primary part of her daily practice rather than a subspecialty adjunct. Her 2016 ISAR Bengal conference presentation on minimal stimulation in poor responders is the clearest external signal of her research engagement with this specific patient group.
Patient testimonials for Dr. Preeti Mahawar consistently describe her personal involvement in patient care, her accessibility for questions between appointments, and her ability to explain complex fertility decisions in a way that reduces rather than increases patient anxiety. One patient conceived in her very first IVF cycle under Dr. Preeti's care after struggling with fertility issues, noting specifically the compassion and clarity that characterised the treatment journey.
What an Initial Consultation With Dr. Preeti Mahawar Covers for DOR
A DOR patient consulting Dr. Preeti Mahawar at Nova IVF Kolkata receives:
-
Complete review of all prior AMH, AFC, FSH, and oestradiol results
-
Concurrent evaluation of the male partner including sperm DNA fragmentation testing
-
Assessment of any contributing factors (endometrioma history, prior surgery, autoimmune markers)
-
A clear recommendation on protocol with explanation of the rationale
-
Honest discussion of own-egg cycle probability versus donor egg pathways
-
Cost-transparent IVF programme design for own-egg cycles, with accumulation strategies where appropriate
Cost of Low Ovarian Reserve Treatment at Nova IVF Kolkata for International Patients
| Treatment | Approximate cost at Nova IVF Kolkata | USA / UK equivalent |
|---|---|---|
| AMH, AFC, baseline workup | Rs. 3,000 to Rs. 6,000 (USD 36 to USD 72) | USD 500 to USD 1,500 |
| IVF cycle with antagonist protocol and ICSI | Rs. 1,50,000 to Rs. 2,50,000 (USD 1,800 to USD 3,000) | USD 15,000 to USD 25,000 |
| Mini-IVF or natural cycle IVF | Rs. 80,000 to Rs. 1,50,000 (USD 960 to USD 1,800) | USD 5,000 to USD 12,000 |
| PGT-A chromosomal screening | Rs. 50,000 to Rs. 1,00,000 (USD 600 to USD 1,200) | USD 3,000 to USD 6,000 |
| Donor egg IVF cycle | Rs. 2,00,000 to Rs. 3,50,000 (USD 2,400 to USD 4,200) | USD 20,000 to USD 40,000 |
-
For more on how age affects each stage of IVF and when donor eggs become relevant, read: Evaluating the IVF Success Rate by Age: When to Consider Donor Programs
-
understanding what each IVF stage involves and how DOR changes the dynamics, read: What Are the 5 Stages of IVF and How Does Age Affect Each Stage?
How Karetrip Connects International Patients to Dr. Preeti Mahawar
Karetrip reviews each couple's ovarian reserve parameters and prior treatment history before recommending Dr. Preeti Mahawar at Nova IVF Kolkata, confirming that her specific DOR expertise matches the patient's clinical situation.
From medical visa coordination and accommodation near the Uttam Kumar Sarani centre, through discharge documentation for post-treatment obstetric follow-up after a positive result, Karetrip manages every element of the international patient journey for the best fertility treatment for low ovarian reserve in India.
Chat with our Medical care assistant, RUA, for quick guidance and support and take the first step toward a DOR-specific fertility programme designed around your reserve parameters.
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. Low ovarian reserve requires evaluation by a qualified fertility specialist. Consult a reproductive endocrinologist before making any treatment decision.